NCT05105087 · OUTCOME

Location of Sentinel Lymph Nodes (SLNs) Identified by Contrast-enhanced Ultrasound (CEUS)

Gynecological Sentinel Lymph Nodes CEUS · Source last updated 2025-08-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: sentinel lymph nodes (SLNs)
Interval / dispersion: Not reported
Time frame: up to 30 minutes during CEUS procedure

Analysis population: Only participants who completed CEUS and surgery (N=5) were analyzed.

Groups in this outcome

Diagnostic (Perflubutane Microbubble, Ultrasound)

Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment. Perflubutane Microbubble: Given subdermally Contrast-Enhanced Ultrasound: Undergo ultrasound

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Diagnostic (Perflubutane Microbubble, Ultrasound)	5

Analysis denominator · sentinel lymph nodes (SLNs)

Group	Source count
Diagnostic (Perflubutane Microbubble, Ultrasound)	17

Reported measurements

Left Inguinal Region

Values in sentinel lymph nodes (SLNs) · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Diagnostic (Perflubutane Microbubble, Ultrasound)	9	Not reported	Not reported	Not reported	Not reported

Left Iliac Region

Values in sentinel lymph nodes (SLNs) · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Diagnostic (Perflubutane Microbubble, Ultrasound)	7	Not reported	Not reported	Not reported	Not reported

Right Iliac Region

Values in sentinel lymph nodes (SLNs) · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Diagnostic (Perflubutane Microbubble, Ultrasound)	1	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
9
title
Left Inguinal Region
categories
measurements
group Id
OG000
value
7
title
Left Iliac Region
categories
measurements
group Id
OG000
value
1
title
Right Iliac Region

denom Units Selected

sentinel lymph nodes (SLNs)

denoms

counts
group Id
OG000
value
5
units
Participants
counts
group Id
OG000
value
17
units
sentinel lymph nodes (SLNs)

groups

description
Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment. Perflubutane Microbubble: Given subdermally Contrast-Enhanced Ultrasound: Undergo ultrasound
id
OG000
title
Diagnostic (Perflubutane Microbubble, Ultrasound)

param Type

NUMBER

population Description

Only participants who completed CEUS and surgery (N=5) were analyzed.

reporting Status

POSTED

time Frame

up to 30 minutes during CEUS procedure

title

Location of Sentinel Lymph Nodes (SLNs) Identified by Contrast-enhanced Ultrasound (CEUS)

type

SECONDARY

type Units Analyzed

sentinel lymph nodes (SLNs)

unit Of Measure

sentinel lymph nodes (SLNs)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice